We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $603M
1-Year Est. Return 32%
This Fund
S&P 500
This Quarter Est. Return
+17.93%
1 Year Est. Return
+32%
3 Year Est. Return
+63.99%
5 Year Est. Return
+46.87%
10 Year Est. Return
+296.03%
AUM
$603M
AUM Growth
+$31.7M
Cap. Flow
-$13.3M
Cap. Flow %
-2.2%
Top 10 Hldgs %
4.32%
Holding
1,374
New
518
Increased
179
Reduced
194
Closed
483

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Industrials 17.11%
3 Financials 15.01%
4 Healthcare 13.93%
5 Consumer Discretionary 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
401
Equifax
EFX
$20.7B
$601K 0.1%
+3,785
New +$645K
CDNA icon
402
CareDx
CDNA
$2.6B
$595K 0.1%
+20,869
New +$454K
SHO icon
403
Sunstone Hotel Investors
SHO
$2.04B
$594K 0.1%
51,853
-10,783
-17% -$113K
CE icon
404
Celanese
CE
$4.95B
$590K 0.1%
+12,834
New +$743K
HEI icon
405
HEICO Corp
HEI
$45.2B
$590K 0.1%
+1,656
New +$504K
ACLS icon
406
Axcelis
ACLS
$3.53B
$588K 0.1%
+3,102
New +$460K
BKR icon
407
Baker Hughes
BKR
$62.6B
$587K 0.1%
10,568
-6,906
-40% -$437K
BEAM icon
408
Beam Therapeutics
BEAM
$3.08B
$586K 0.1%
+17,072
New +$515K
SMCI icon
409
Super Micro Computer
SMCI
$26.7B
$585K 0.1%
+19,940
New +$635K
TCBI icon
410
Texas Capital Bancshares
TCBI
$4.29B
$584K 0.1%
+5,655
New +$567K
LITE icon
411
Lumentum
LITE
$78.6B
$583K 0.1%
+680
New +$607K
WAL icon
412
Western Alliance Bancorporation
WAL
$8.86B
$582K 0.1%
+7,083
New +$559K
TGTX icon
413
TG Therapeutics
TGTX
$8.62B
$580K 0.1%
+10,560
New +$432K
AGIO icon
414
Agios Pharmaceuticals
AGIO
$1.98B
$580K 0.1%
+15,622
New +$474K
CECO icon
415
Ceco Environmental
CECO
$4.39B
$579K 0.1%
+6,379
New +$504K
GPCR icon
416
Structure Therapeutics
GPCR
$3.37B
$578K 0.1%
+10,776
New +$477K
ADC icon
417
Agree Realty
ADC
$9.05B
$578K 0.1%
+7,629
New +$578K
MTN icon
418
Vail Resorts
MTN
$4.84B
$577K 0.1%
4,241
-2,876
-40% -$374K
HAE icon
419
Haemonetics
HAE
$4.7B
$575K 0.1%
+7,663
New +$492K
DHT icon
420
DHT Holdings
DHT
$3.35B
$573K 0.1%
34,689
-16,746
-33% -$299K
CRSP icon
421
CRISPR Therapeutics
CRSP
$5.4B
$572K 0.09%
+10,490
New +$553K
HUM icon
422
Humana
HUM
$48.1B
$571K 0.09%
1,438
-4,208
-75% -$1.2M
BEN icon
423
Franklin Templeton
BEN
$17.7B
$570K 0.09%
+17,141
New +$513K
NNN icon
424
NNN REIT
NNN
$8.6B
$568K 0.09%
+12,217
New +$546K
ASIX icon
425
AdvanSix
ASIX
$469M
$568K 0.09%
+28,566
New +$643K

Similar funds

Fox Run Management's Q2 2026 Portfolio in Review

As of Q2 2026, Fox Run Management held 1,374 positions worth $603M, up 5.5% from $572M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

Fox Run Management's Q2 2026 filing shows 518 new, 179 increased, 194 reduced and 483 closed positions. Its largest new stake was Zoetis: 29,511 shares worth $2.12M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $7.85M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.

  • Fox Run Management's largest Q2 2026 buy was Zoetis: 29,511 shares worth $2.12M.
  • Fox Run Management added most to Intercontinental Exchange in Q2 2026, an estimated $2.5M increase.
  • Fox Run Management's biggest Q2 2026 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $7.85M.
  • Fox Run Management fully exited Cummins in Q2 2026, selling an estimated $2.64M.
  • Fox Run Management's ten largest holdings make up 4.3% of its $603M portfolio in Q2 2026.
  • Fox Run Management opened 518 new positions and closed 483 in Q2 2026.
  • Fox Run Management's portfolio value rose 5.5% quarter-over-quarter to $603M.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.